Dr. So's research focuses on how human genetic variation influences cardiac and cardiac-related diseases. As a staff research scientist in the laboratory of Gladstone Senior Investigator Bruce Conklin, MD, Dr. So manages and oversees on-going projects in the Conklin Lab, including the current use of induced pluripotent stem (iPS) cell technology and TALEN genome editing strategies to investigate the significance of genetic changes on cardiac disease.
Before coming to Gladstone in 2011, Dr. So was an assistant staff scientist at Children’s Hospital Research Institute in Oakland, CA, and a postdoctoral fellow at University of California, San Francisco, CA, where she conducted translational skin cancer research. She also received postdoctoral fellowships in developmental and translational neurobiology at the Institute of Cancer Research in London, and King’s College, University of London. Dr. So received her bachelor’s in genetics at Queen Mary College, University of London and her PhD in developmental biology from King’s College.